Form D · Pharmaceuticals
ALNARA PHARMACEUTICALS INC
Cambridge, MA · CIK 0001448422
Offering snapshot reported Feb 4, 2010 · SEC filing
- Reported sold
- $20M Offering amount: $35M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 25, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 4, 2010 | Initial | $19,994,431 | No comparison | 9 | SEC filing |
| Oct 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-123629
Source: Form D, filed Feb 4, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard H. Aldrich | Director |
| Lee Brettman | Executive |
| Ashley Dombkowski | Director |
| Robert Gallotto | Executive |
| Alexey Margolin | Director, Executive |
| Robert Tepper | Director |
| James N. Topper | Director |
| Christoph H. Westphal | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
840 Memorial Drive
Cambridge, MA, 02139
Cambridge, MA, 02139